07:00 , May 20, 2002 |  BC Week In Review  |  Company News

AlphaGene genomics, bioinformatics news

AlphaGene reduced its workforce to 1 from 30 and said it is looking for a buyer. Last fall, the company enlisted UBS Warburg in efforts to seek strategic alternatives. AlphaGene Inc., Woburn, Mass.   Business: Genomics,...
08:00 , Jan 14, 2002 |  BioCentury  |  Finance

Hat in Hand?

Hat in Hand? Company Raised in 1H00 Notes diaDexus $102.5M Filed for IPO in11/00 Athersys $47.5M Withdrew IPO on 4/01 DoubleTwist $37.0M Withdrew IPO on 3/01 Structural Bio ...
08:00 , Nov 19, 2001 |  BC Week In Review  |  Company News

AlphaGene, Celera Genomics Group deal

AlphaGene granted CRA distribution rights to its collection of human full-length genes. AlphaGene will isolate, sequence and manufacture known clones found in public databases through its Clone Database, and CRA will market the service through...
08:00 , Nov 13, 2001 |  BC Extra  |  Company News

Celera, AlphaGene gene distribution deal

AlphaGene granted CRA distribution rights to its collection of human full-length genes. AlphaGene will isolate, sequence and manufacture known clones found in public databases through its Clone Database, and CRA will market the product through...
07:00 , Sep 17, 2001 |  BC Week In Review  |  Company News

AlphaGene, Wayne State University deal

AlphaGene will collaborate with the university's Karmanos Cancer Institute to identify patterns of gene expression in malignant brain tumor cells and to correlate the expression patterns with treatment regimens to develop diagnostic and prognostic tools....
07:00 , Aug 27, 2001 |  BioCentury  |  Finance

Money Hunters

Money Hunters Company Amt raised in 1H00 Notes diaDexus $102.5M Filed for IPO 11/20/00 Athersys $47.5M Withdrew IPO 4/17/01 DoubleTwist $37.0M Withdrew IPO 3/7/01 Structural Bio...
07:00 , Aug 27, 2001 |  BioCentury  |  Finance

Money Hunters

Money Hunters Company Amt raised in 1H00 Notes diaDexus $102.5M Filed for IPO 11/20/00 Athersys $47.5M Withdrew IPO 4/17/01 DoubleTwist $37.0M Withdrew IPO 3/7/01 Structural Bio...
07:00 , Jul 16, 2001 |  BC Week In Review  |  Company News

AlphaGene, Lahey Clinic deal

AlphaGene and the clinic will study the role of prostate-specific carcinoembryonic antigen (CEA) in prostate cancer, including a comparison of prostate CEA splice variants and their relationship to various stages of disease. The deal...
07:00 , Jun 25, 2001 |  BC Week In Review  |  Company News

AlphaGene, Questar deal

The companies will use Questar's bioinformatics technology to mine AlphaGene's protein library. Questar will provide bioinformatics support for structure determination, pathway identification and small molecule library development. Questar also will make an...
07:00 , Jun 18, 2001 |  BC Week In Review  |  Company News

AlphaGene other research news

AlphaGene said it found two previously unidentified human insulin receptors by mining its internal database and that these receptors could be targets to treat diabetes. It said it also discovered a receptor involved in pancreatic...